The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $21.81

Today's change-0.33 -1.49%
Updated November 28 1:02 PM EST. Delayed by at least 15 minutes.
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $21.81

Today's change-0.33 -1.49%
Updated November 28 1:02 PM EST. Delayed by at least 15 minutes.

PharMerica Corp down (U.S.)$0.33

PharMerica Corp closed lower Friday, dropping (U.S.)$0.33 or 1.49% to (U.S.)$21.81. Shares have lost 3.54% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 14.18% during the last year.

Key company metrics

  • Open(U.S.) $22.13
  • Previous close(U.S.) $22.14
  • High(U.S.) $22.38
  • Low(U.S.) $21.78
  • Bid / Ask-- / --
  • YTD % change+1.44%
  • Volume77,565
  • Average volume (10-day)281,073
  • Average volume (1-month)281,099
  • Average volume (3-month)249,676
  • 52-week range(U.S.) $19.40 to (U.S.) $30.48
  • Beta1.17
  • Trailing P/E84.81×
  • P/E 1 year forward13.27×
  • Forward PEG1.33×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.26
Updated November 28 1:02 PM EST. Delayed by at least 15 minutes.
S&P TSX1.19%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue470449452451
Total other revenue--------
Total revenue470449452451
Gross profit83828081
Total cost of revenue387367372369
Total operating expense457458442437
Selling / general / administrative56585758
Research & development--------
Depreciation / amortization5444
Interest expense (income), net operating--------
Unusual expense (income)92986
Other operating expenses, total--------
Operating income13-101014
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax11-12811
Income after tax9-1054
Income tax, total2-237
Net income9-1054
Total adjustments to net income--------
Net income before extra. items9-1054
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9-1054
Inc. avail. to common incl. extra. items9-1054
Diluted net income9-1054
Dilution adjustment--0--0
Diluted weighted average shares31303030
Diluted EPS excluding extraordinary itemsvalue per share0.28-0.320.160.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.520.310.320.27